Ionis Pharmaceuticals Overview
Ionis Pharmaceuticals Target Price
Analysts' 12-month price predictions for IONS.
Share Price
$69.15
Average Target Price
$72.80
5.3% upside
5.3% upside15 analysts in the last 4 months
High: $96 | Low: $43
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-09-26 | Goldman Sachs | $65 |  6% downside |  |
| 2025-09-23 | BarclaysGena Wang | $82 | 18.6% upside | |
| 2025-09-22 | Raymond JamesGary Nachman | $75 | 8.5% upside | |
| 2025-09-04 | RBC Capital | $80 | 15.7% upside | |
| 2025-09-03 | BMO CapitalKostas Biliouris | $70 | 1.2% upside | |
| 2025-09-02 | BarclaysGena Wang | $78 | 12.8% upside | |
| 2025-09-02 | Morgan StanleyMichael Ulz | $71 | 2.7% upside | |
| 2025-09-02 | Jefferies | $96 | 38.8% upside | |
| 2025-09-02 | H.C. WainwrightMitchell Kapoor | $95 | 37.4% upside | |
| 2025-08-22 | H.C. Wainwright | $70 | 1.2% upside | |
| 2025-08-22 | Wells FargoYanan Zhu | $82 | 18.6% upside | |
| 2025-08-22 | Barclays | $58 | 16.1% downside | |
| 2025-08-21 | Stifel Nicolaus | $43 | 37.8% downside | |
| 2025-07-31 | H.C. Wainwright | $65 | 6% downside | |
| 2025-07-30 | Morgan Stanley | $62 | 10.3% downside | |
| 2024-10-09 | GuggenheimDebjit Chattopadhyay | $65 | 6% downside | |
| 2024-08-02 | BMO CapitalKostas Biliouris | $60 | 13.2% downside | |
| 2024-07-24 | Leerink PartnersMani Foroohar | $62 | 10.3% downside | |
| 2024-07-22 | JefferiesAkash Tewari | $77 | 11.4% upside | |
| 2024-07-22 | Goldman SachsSalveen Richter | $33 | 52.3% downside | |
| 2024-07-16 | JefferiesAkash Tewari | $75 | 8.5% upside | |
| 2024-06-27 | Stifel NicolausPaul Matteis | $53 | 23.4% downside | |
| 2024-06-17 | RBC CapitalLuca Issi | $70 | 1.2% upside | |
| 2024-06-14 | Tudor PickeringWilliam Pickering | $44 | 36.4% downside | |
| 2024-05-17 | BMO CapitalKostas Biliouris | $67 | 3.1% downside | |
| 2023-02-03 | Leerink Partners | $34 | 50.8% downside | |
| 2022-12-21 | Morgan Stanley | $40 | 42.2% downside | |
| 2022-08-10 | Citigroup | $28 | 59.5% downside | |
| 2022-08-10 | RBC Capital | $64 | 7.4% downside | |
| 2022-06-21 | Piper SandlerDo Kim | $55 | 20.5% downside | |
| 2022-06-21 | Leerink Partners | $27 | 61% downside | |
| 2022-05-09 | Morgan Stanley | $30 | 56.6% downside | |
| 2022-02-24 | NeedhamJoseph Stringer | $60 | 13.2% downside | |
| 2022-02-24 | RBC CapitalLuca Issi | $67 | 3.1% downside | |
| 2022-02-01 | Bank of America SecuritiesJason Gerberry | $30 | 56.6% downside | |
| 2021-11-04 | BarclaysGena Wang | $33 | 52.3% downside | |
| 2021-10-18 | LaidlawYale Jen | $68 | 1.7% downside | |
| 2021-05-10 | UBSEsther Rajavelu | $37.5 | 45.8% downside | |
| 2021-05-05 | OppenheimerKevin DeGeeter | $63 | 8.9% downside | |